Program

ISCT NA Program

 PROGRAM AT A GLANCE 

 PLENARY SESSIONS 

 CONCURRENT SESSIONS 

The Sweden Ecosystem: A Route from Concept Creation to Product Delivery

CHAIR: Johan Hyllner, PhD, AstraZeneca/Linköping University, Gothenburg, Sweden

SPEAKERS: 

  • Veronique Chotteau, PhD, KTH Royal Institute of Technology/AdBIOPRO, Stockholm, Sweden
  • Anna Falk, PhD, Lund University/CCRM Nordic, Lund, Sweden
  • Kristina Levan, PhD, Precision Medicine, Gothenburg, Sweden

ATMP Regulatory Interplay: The Jeopardized Quality and Regulatory Standards of Cellular Based Starting Materials in an Era of Regulatory Resilience and Harmonization

CHAIR: Michela Gabaldo, PharmD, EVOTEC, Verona, Italy

SPEAKERS: 

  • Jacqueline Barry, PhD, Cell and Gene Therapy Catapult, Edinburgh, United Kingdom
  • Ilona Reischl, PhD, Assessor, AGES, MEA, Vienna, Australia
  • Stefaan van der Spiegel, MD, MBA, European Commission, Brussels, Belgium

Current Use of iPSC to Fill Unmet Clinical Gaps

CHAIR: TBD

SPEAKERS:

  • Massimiliano Gnecchi, MD, PhD, University of Pavia, Italy
  • Begoña Aran, PhD, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain

Understanding and Developing Your Manufacturing Process - From Phase I to Commercialisation

CHAIR: Ricardo Baptista, PhD, SmartCella, Stockholm, Sweden

SPEAKERS: 

  • Rob Allen, PhD, DHC Europe Ltd Dark Horse Consulting, England United Kingdom
  • Clothilde Decarnin, Merck Life Science, Switzerland
  • Marcia Mata, PhD, Cell and Gene Therapy Catapult, London, United Kingdom

Innovations in TIL Therapy: Melanoma Trials and Beyond

CO-CHAIRS: 

  • Erja Kerkela, PhD, Finnish Red Cross Blood Service, Finland
  • Anna Pasetto, PhD, Oslo University Hospital, Norway

SPEAKERS: 

  • Victor Cervera, PhD, Tilt Biotherapeutics, Helsinki, Finland
  • Özcan Met, PhD, Herlev and Gentofte Hospital, Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark
  • Stina Wickström, PhD, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Breaking Manufacturing Boundaries: Who Will Conquer the Scalability Strategy?

CHAIR: Michael Delahaye, EngD, AstraZeneca, Gothenburg, Sweden

SPEAKER: 

  • Daria Donati, PhD, Cytiva, Uppsala, Sweden
  • Robert Zweigerdt, PhD, Hannover Medical School (MHH), Hannover, Germany 

Application for Mesenchymal Stromal Cells - Focusing on the Clinical Indication

CHAIR: TBD

SPEAKERS: 

  • Lindsay Davies, PhD, FHEA, NextCell Pharma, Sweden
  • Dominique Farge, MD, PhD, Paris University, Paris, France
  • Damian Garcia Olmo, MD, PhD, Autonomous University of Madrid, Madrid, Spain

Regulatory Considerations for Early Development in the CGT Product Lifecycle

CHAIR: Margareth Jorvid, MSc Pharm, MSc MTRA, MBA, Methra Uppsala AB, Sweden

SPEAKERS: 

  • Miguel Forte, MD, PhD, mC4Tx, Rixensart, Belgium
  • Anna Koptina Gültekin, PhD, Mendus AB, Stockholm, Sweden

Standardisation: A Cornerstone of Product Efficacy and Safety

CHAIR: Elsa Abranches, PhD, AstraZeneca, Gothenburg, Sweden

SPEAKER: 

  • Julian Braybrook, PhD, LGC, United Kingdom

EU LRA Concurrent Session
Raw and Starting Material Challenges in CAR-T Manufacturing

CHAIR:

  • Bernd Schröder, PhD, Miltenyi Biotec B.V. & Co. KG, Teterow, Germany
  • Carmen Sanges, PhD, Universitätsklinikum Würzburg, Würzburg, Germany 

SPEAKER: 

  • Carole Moukheiber, PharmD, Servier, Paris, France
  • Bernd Schröder, PhD, Miltenyi Biotec B.V. & Co. KG, Teterow, Germany
  • Nina Worel, MD, PhD, Medical University of Vienna, Vienna, Austria

New Frontiers in Genetic Engineering: A Biological Recipe to Gene-Modified Cell Therapies

CHAIR: Vincenzo Di Cerbo, PhD, Cell and Gene Therapy Catapult, London, United Kingdom

SPEAKERS: 

  • Marco Alessandrini, PhD, Antion Bio, Geneva, Switzerland
  • Benjamin Klapholz, PhD, bit.bio, Cambridge, United Kingdom
  • Luke Pase, PhD, Anocca AB, Södertälje, Sweden 

Cell and Gene Therapy Cold Chain Management: From Logistics to Product Design

CHAIR: Dominic Clarke, PhD, Cryoport Systems, United States

SPEAKERS: 

  • Dominic Clarke, PhD, Cryoport Systems, United States
  • Lindsay Davies, PhD, FHEA, NextCell Pharma, Sweden
  • Ivo Urh, MSc, Fujifilm Irvine Scientific, London, United Kingdom

Stem Cell Based Gene Therapy, the Promise of a Life-Long Cure?

CHAIR: Jaap Jan Zwaginga, MD, PhD, Leiden University, Leiden, Netherlands

SPEAKERS: 

  • Marina Cavazzana, MD, PhD, Département de Biothérapie - Hôpital Necker-Enfants Malades, Assistance Publique–Hôpitaux de Paris, Centre d’Investigation Clinique en Biothérapie, INSERM VMR1163, Imagine Institute, Université Paris Cité, Paris, France
  • Johan Flygare, MD, PhD, Lund University, Lund, Sweden
  • Frank J.T. Staal, PhD, Leiden University Medical Center, Leiden, Netherlands

ISCT-ISEV Joint Session: Advancing the Translation of Extracellular Vesicle and Secretome-Based Therapeutics

CO-CHAIRS: 

  • Massimiliano Gnecchi, MD, PhD, University of Pavia, Italy
  • Benedetta Bussolati, PhD, President-Elect of the International Society for Extracellular Vesicles, University of Turin, Torino, Italy

SPEAKER: 

  • Benedetta Bussolati, PhD, President-Elect of the International Society for Extracellular Vesicles, University of Turin, Torino, Italy
  • Jan Lötvall, MD, PhD, University of Gothenburg, Editor-in-Chief for Journal of Extracellular Vesicles, ISEV, Gothenburg, Sweden 
 ROUNDTABLES 

Moderators: 

  • Joaquim Vives, PhD, Banc de Sang I Teixits, Barcelona, Spain
  • Jaap Jan Zwaginga, MD, PhD, Leiden University, Leiden, Netherlands

Panelist:

  • Gloria Carmona Sanchez, MSc, Andalusian Network for the Design and Translation of Advanced Therapies (And&TAT), Seville, Spain


Moderator: TBD

Panelist: 

  • Daniela Bellomo, PhD, MBA, San Raffaele Hospital, Milan, Italy 







Moderator: TBD

Panelists: TBD











Moderator:

  • Björn Skölving, BSc, Orchard Tx, Sundsvall, Sweden

Panelists:

  • Peter Carlqvist, MSc, PhD, Nordic Market Access, Stockholm, Sweden
  • Fredrik Eisner, MBA, Parexel, Alingsås, Sweden
  • Björn Skölving, BSc, Orchard Tx, Sundsvall, Sweden



Moderator:

  • Fermin Sanchez-Guijo, MD, PhD, University Hospital of Salamanca, Spain

Panelists:

  • Dominique Farge, MD, PhD, Paris University, Paris, France
  • Isabel Sánchez-Ortega, MD, PhD, EBMT, Barcelona, Spain
  • Ben Weil, EngD, MBA, INmune Bio, London, United Kingdom


Moderators: 

  • Joaquim Vives, PhD, Banc de Sang I Teixits, Barcelona, Spain
  • Jaap Jan Zwaginga, MD, PhD, Leiden University, Leiden, Netherlands

Panelists:

  • Dominique de Jong, MSc, RegMed XB, Leiden, Netherlands
  • Jim Lund, PhD, CCRM Nordic, Karlskoga, Sweden


 MORE UPCOMING CONCURRENTS & ROUNDTABLES 
  • Use of gene editing technologies  - CAS, AAV, CRISPR
  • Novel methods for isolation of secretomes and EVs
  • Potency Assays from assay design to clinical validation
  • IP development and strategy

... and many more. Stay tuned for more confirmed speakers and session details.